Following an investigation by The Guardian that found Google AI Overviews offering misleading information in response to certain health-related queries, the company appears to have removed the AI ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Google announced new branded queries filters are rolling out gradually within Google Search Console reporting. You can filter your performance reports by branded or non-branded queries and Google can ...

So far this year, electricity use in the US is up nearly 4 percent compared to the same period the year prior. That comes after decades of essentially flat use, a change that has been associated with ...

Update 7/31/25 4:10pm PT: Hours after this article was published, OpenAI said it removed the feature from ChatGPT that allowed users to make their public conversations discoverable by search engines.

This tool helps to analyze the MySQL/MariaDB binary log files. The generated report will give an overview of how many UPDATE, INSERT, DELETE, DROP and TRUNCATE operations appear in the binary logs.

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...